Literature DB >> 20936527

Immunohistochemical and transcriptional expression of matrix metalloproteinases in full-term human umbilical cord and human umbilical vein endothelial cells.

Annamaria Mauro1, Maria Buscemi, Aldo Gerbino.   

Abstract

Matrix metalloproteinases (MMPs) are extracellular zinc-dependent endopeptidases involved in the degradation and remodelling of extracellular matrix in physiological and pathological processes. MMPs also have a role on cell proliferation, migration, differentiation, angiogenesis and apoptosis. Umbilical cord is a special organ subjected to many changes during pre-natal life and whose cells can maintain a certain degree of plasticity also in post-natal period; for example recently they have been used as a source of stem cells. In this work we investigated the expression of MMPs in human umbilical cord and human umbilical vein endothelial cells (HUVEC) though immunohistochemistry, RT-PCR and gelatin zymography. MMP-2 protein is expressed in the amniotic epithelium of human umbilical cord and in few sub-epithelial fibroblasts, while MMP-3 and MMP-10 only in the umbilical epithelium. MMP-8, MMP-9 and MMP-13 immunoreactivity is localised in the epithelium and in Wharton's jelly mesenchymal cells. Immunocytochemistry also revealed protein expression for MMP-2, 3, 8, 9 and 10 in cultured HUVEC. In agreement with immunohistochemical data, RT-PCR analysis performed on samples of whole umbilical cord confirmed the transcriptional expression for the genes encoding all the six matrix metalloproteinases investigated, while in HUVEC only the expression of MMP-2, 3, 9, 10 and 13 mRNAs was detected. Gelatin zymography showed a clear MMP-2 and MMP-9 enzymatic activity in the conditioned medium of HUVEC at different culture passages, suggesting that HUVEC secrete gelatinases, that afterwards undergo extracellular activation, and this ability is not affected by passage number.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936527     DOI: 10.1007/s10735-010-9298-y

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 2.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

3.  Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling.

Authors:  Carl Whatling; William McPheat; Eva Hurt-Camejo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-01       Impact factor: 8.311

4.  Transformation of human umbilical mesenchymal cells into neurons in vitro.

Authors:  Yu-Show Fu; Yu-Tsung Shih; Yun-Chih Cheng; Ming-Yuan Min
Journal:  J Biomed Sci       Date:  2004 Sep-Oct       Impact factor: 8.410

Review 5.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

6.  Functional characterization of HUVEC-CS: Ca2+ signaling, ERK 1/2 activation, mitogenesis and vasodilator production.

Authors:  S M Gifford; M A Grummer; S A Pierre; J L Austin; J Zheng; I M Bird
Journal:  J Endocrinol       Date:  2004-09       Impact factor: 4.286

7.  Enhanced proliferation of human umbilical vein endothelial cells and differentiation of 3T3-L1 adipocytes in coculture.

Authors:  Ning Lai; Arul Jayaraman; Kyongbum Lee
Journal:  Tissue Eng Part A       Date:  2009-05       Impact factor: 3.845

8.  Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin.

Authors:  Monika Krampert; Wilhelm Bloch; Takako Sasaki; Philippe Bugnon; Thomas Rülicke; Eckhard Wolf; Monique Aumailley; William C Parks; Sabine Werner
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

9.  Activation of cartilage matrix metalloproteinases by activated protein C.

Authors:  Miriam T Jackson; Margaret M Smith; Susan M Smith; Christopher J Jackson; Meilang Xue; Christopher B Little
Journal:  Arthritis Rheum       Date:  2009-03

10.  Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices.

Authors:  Guido Krenning; Jan-Renier A J Moonen; Marja J A van Luyn; Martin C Harmsen
Journal:  Biomaterials       Date:  2008-06-16       Impact factor: 12.479

View more
  6 in total

1.  Development of a mathematical model to describe the transport of monocyte chemoattractant protein-1 through a three-dimensional collagen matrix.

Authors:  Krisada Leemasawatdigul; Heather Gappa-Fahlenkamp
Journal:  Cardiovasc Pathol       Date:  2011-11-18       Impact factor: 2.185

2.  Mechanisms for redox actions of nicotine and glutathione in cell culture, relevant to periodontitis.

Authors:  Federico Tinti; Mena Soory
Journal:  Sci Rep       Date:  2012-08-08       Impact factor: 4.379

3.  Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and -9: an in vitro study.

Authors:  Hua Gao; Jingjing Zhang; Ting Liu; Weiyun Shi
Journal:  Mol Vis       Date:  2011-12-24       Impact factor: 2.367

4.  Anabolic Actions of the Regenerative Agent Enamel Matrix Derivative (EMD) in Oral Periosteal Fibroblasts and MG 63 Osteoblasts, Modulation by Nicotine and Glutathione in a Redox Environment.

Authors:  Tareq Al-Qattan; Mena Soory
Journal:  J Funct Biomater       Date:  2012-02-29

Review 5.  Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications.

Authors:  E Russo; M Caprnda; P Kruzliak; P G Conaldi; C V Borlongan; G La Rocca
Journal:  Stem Cells Int       Date:  2022-01-06       Impact factor: 5.443

6.  Endothelialization of an ePTFE vessel prosthesis modified with an antithrombogenic fibrin/heparin coating enriched with bound growth factors.

Authors:  Johanka Táborská; Zuzana Riedelová; Eduard Brynda; Pavel Májek; Tomáš Riedel
Journal:  RSC Adv       Date:  2021-02-03       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.